The PHARM Connect Congress - PHARM Connect Programme & Speakers
For the 9th time on 12-13 March 2019  
Budapest, Hungary Login to meeting scheduler demo CZE ENG HUN POL ROU
PHARM Connect Programme & Speakers

PHARM Connect Congress 2018 will bring you an overview of the Central Eastern European market and the main trends and impacts on the pharmaceutical manufacturing & biotechnology world.

For speaking opportunities please contact

Katy Säurich, Operations & Production Manager at TEG

Email: | Tel: + 36 1 219-57-25


Biotech and R&D:

Dr. András Ballagi

Chief Technology Officer, Diagon


Prof. Dr. Romána Zelkó

Dean Faculty of Pharmacy, Semmelweis University


Prof. Dr. Stane Srčič

Head of Pharmaceutical Technology Department, Faculty of Pharmacy, University of Ljubljana


Assoc. Prof. Dr. Ildikó Csóka

Director of the Institute of Pharmaceutical Technology and Regulatory Affairs

Faculty of Pharmacy, University of Szeged



Opening Keynote Presentation:

Biosimilars: Opportunities and Challenges for Pharmaceutical Industry. Pegfilgrastim Case Study

• Biologics, biosimilars, generics – facts and definitions

• Biosimilar market trends

• Pegfilgrastim case study: focus on clinical development and Phase III study considerations

Anna Aillerie, Head of Commercial Operations, Biotechnology Business Unit, Gedeon Richter

András Illés, Deputy Head of Clinical Development of Biologics, Gedeon Richter


Enabling smooth product life cycling – process characterization on sound data science and QbD tools  

Process characterization is a central tool in process validation from step 1 to 3 in the product life cycle. We need:

• Advanced statistics to be deployed to define NORS and PARs

• Models for experimental design, scale down models qualification and real-time predictive control


Univ. Prof. Dr. Christoph Herwig, Head of Research Division Biochemical Engineering, Institute of Chemical Environmental and Biological Engineering, Vienna University of Technology

Case Study Presentation:

Making it fit: The challenges of transferring new products into a running facility

• Key considerations of balancing project speed with manufacturing continuity

• An overview of the main risks of infrastructure modifications around (and inside) a running GMP unit

• Our key lessons learned and how we are executing further transfers effectively

• Interesting challenge - Transferring similar technologies


Judit Sallai, Technology Transfer Project Leader, GSK Biologicals Kft.

Christopher Hunley,Site Head and Managing Director, GSK Biologicals Kft. 

Case Study Presentation:

Implementing Single-use Continuous Bioprocessing: A case study on large-scale continuous mAb purification

• Process intensification through continuous bioprocessing

• Case study on large-scale continuous mAb purification

• Regulatory aspects of continuous bioprocessing


Britta Badertscher, MSc, Technical Specialist SLS, Pall International SARL


Three Dimensional Printing (3DP) technology in Pharmaceutical Manufacturing

• Technology description

• 3DP techniques & examples

• Spritam – first 3D printed drug product

• Advantages and challenges


Marek Cichocki, Head of Operational R&D, Polpharma


Case Study Presentation:

Quality by Design (QbD) Approach in Formulation Development

• FDA’s Initiative on Quality by Design (QbD)

• Introduction of QbD and its role in improvement of Quality

• The current Vs QbD approach of formulation development

• Five-step QbD methodology, key aspects and tools of QbD and Formulation by Design (FbD)


Dr. Devendra Ridhurkar, Senior Scientist (Special Formulations), Egis Pharmaceuticals


Case Study Presentation:

Orally Disintegrating Tablets and Films:

A Modern Innovative Drug Delivery System


Prof. Vladimír Král, Group Leader & Professor of Medicinal Chemistry, University of Chemistry and Technology, Prague & Medical School Charles University, BIOCEV Institute

Case Study Presentation:

Optimization of lyophilization process for the parenteral product

• Using PAT tools at the production scale

• Production scale up of the parenteral product

• Development of new lyo cycle in order to reduce total production cost (TPC) and increase production capacity


Dr. Aljoša Maglica, Product Steward Senior, Lek Pharmaceuticals d.d. / Novartis

Case Study Presentation:

Continuous manufacturing into the context of product development

• Critical factors to be considered and assessed upfront

• Early vs. late phase, in continuous product development

• Building the team and the technical confidence


Massimo Bresciani, Executive Director Scientific Operations & Board Member

Research Centre for Pharmaceutical Engineering (RCPE)

Case Study Presentation:

Xellia Central Laboratory Services case study

• Xellia history, present and future in a nutshell

• Central Laboratory Services concept and what is behind

• How to select, attract and integrate new colleagues considering the current challenging labor market


Eva Farkas, Quality Director, Head of Centralized Laboratory Services, Xellia


Case Study Presentation:

How to manage process deviations and showcase your data

A Laboratory case study

• Increase employees awareness around the concept „total cost of deviations“, as human errors are very often the main culprit

• Reduce process deviations from a daily to a monthly event, so that you can invest your time working on effective preventive actions rather than fire-fighting

• Present your data in the right way after all the hard work done: how to use the concepts of “Defect-free“ & 6-Sigma analysis


Eugenio Filippi, Associate Director Plasma Logistics & Analytics Europe, Shire


 How to handle impurities in general?

 • The improving analytical methods are able to show even the trace of impurities

 • Where is the limit of the increasing purity requirements?

 • How to satisfy regulatory requirements?

 • New guidelines for Elemental Impurities - Implementation best practice examples

Dr. Devendra Ridhurkar

Senior Scientist (special formulations), Egis Pharmaceuticals

Lenka Francišković

Head of Processes and Products Quality, Belupo Pharmaceuticals

Dr. Katalin Ganzler

Head of the Analytical Division, Formulation R&D delivery, Gedeon Richter  





The CEE Pharmaceutical Manufacturing Excellence Award has been established to honour, recognise and promote outstanding manufacturing excellence solutions in the rapidly growing region of CEE. Manufacturers as well as solution providers were welcome to apply with their most innovative projects and methods implemented in the region. The winners have the opportunity to present their projects at PHARM Connect 2018.

Applications should be submitted by the 31st of January 2018 and will be assessed by our highly renowned jury.

For further information please click here.


PRE-EVENT PROGRAMME | 12th March 2018

Site visit to Meditop Pharmaceutical - The Winner of the 3rd CEE Pharmaceutical Manufacturing Excellence Award in 2017


Participants of PHARM Connect 2018 can learn more about the award winning innovation and visit the Meditop Pharmaceutical plant near Budapest. It is limited for 30 delegates only and available on a complimentary, first-come, first-served basis at 15:00 on 12th March.

Meditop Pharmaceutical Ltd. as a middle size company develops and manufactures its own products and offers services as a Contract Manufacturing Organisation to produce solid dosage forms in flexible manner and to provide support in development and manufacturing of pharmaceutical and nutraceutical products suffering with special sensitivity.

Meditop Pharmaceutical developed an innovative approach to improve film coating efficiency with developing and applying of a continuous film coater for which they received the 3rd CEE Pharmaceutical Manufacturing Excellence Award in 2017. With the innovation they:

• Successfully developed a method to coat soft tablets with high quality,

• Managed to coat heat sensitive actives without degradation,

• Saved considerable time and energy, and

• Obtained flexible and fast change-over and batch size change. 


TRANSFER: The bus will leave in front of the CORINTHIA Hotel at 14:00 on 12th March and will return after the visit at approximately 18:00.

POST-EVENT PROGRAMME | 14th March 2018

Site visit to the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK)


The congress provides the opportunity to visit the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK) in Budapest; this is limited for 60 delegates only and available on a complimentary, first-come, first-served basis at 17:00 on 14th March. The MTA Research Centre for Natural Sciences carries out multidisciplinary research in natural sciences. 

Priorities are given to the following disciplines:

• Materials- and environmental chemistry

• Cognitive neuroscience and psychology

The visit will start with a short, introductory presentation about the MTA TTK. Afterwards, the delegates will have the opportunity to choose a tour to the two research institutes:

Materials- and environmental chemistry

Research of discovery and experimental development in some key areas of materials- and environmental science, with special emphasis on chemical aspects thereof. Exploratory research in the field of nanoscale functional materials and application of the results in integrated nano/micro systems.

Cognitive neuroscience and psychology

Research of discovery and applications in experimental psychology, human-, developmental and comparative psychophysiology, social development psychology, social psychology and cultural psychology.


TRANSFER: The bus will leave in front of the CORINTHIA Hotel at 16:00 on 14th March and will return after the visit at approximately 20:00.


Excursion Partner


Excursion Partner

View further sponsors

Sample list of sponsors

View further sponsors


Lead Association Partner

Hungarian Pharmaceutical Manufacturers Association

View more

Exclusive Hungarian Media Partner

MarketingPirula- PirulaTrend

View more

The Events Group | More Information | Contact Us | BOOK NOW
TheEventsGroup © 2012 | Privacy Policy | Terms Of Use
Design: Nortyx Program: Nortyx Web and Recording studio, Stage technic